J. YAMAHARA

1.1k total citations
31 papers, 959 citations indexed

About

J. YAMAHARA is a scholar working on Molecular Biology, Complementary and alternative medicine and Cancer Research. According to data from OpenAlex, J. YAMAHARA has authored 31 papers receiving a total of 959 indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 11 papers in Complementary and alternative medicine and 6 papers in Cancer Research. Recurrent topics in J. YAMAHARA's work include Natural product bioactivities and synthesis (8 papers), Traditional Chinese Medicine Analysis (4 papers) and Synthesis and Biological Activity (4 papers). J. YAMAHARA is often cited by papers focused on Natural product bioactivities and synthesis (8 papers), Traditional Chinese Medicine Analysis (4 papers) and Synthesis and Biological Activity (4 papers). J. YAMAHARA collaborates with scholars based in Japan, Australia and China. J. YAMAHARA's co-authors include Hisashi Matsuda, Basil D. Roufogalis, Guang Peng, George Li, Tom Huang, Yifan Li, Bhavani Prasad Kota, N. MURAKAMI, Naoto Chatani and Y. Naitoh and has published in prestigious journals such as Journal of Pharmacology and Experimental Therapeutics, British Journal of Pharmacology and Cancer Letters.

In The Last Decade

J. YAMAHARA

30 papers receiving 888 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. YAMAHARA Japan 15 334 211 187 166 162 31 959
M. A. Ocete Spain 13 378 1.1× 346 1.6× 158 0.8× 63 0.4× 79 0.5× 16 1.2k
Johji YAMAHARA Japan 20 633 1.9× 385 1.8× 260 1.4× 130 0.8× 136 0.8× 25 1.2k
Sirpa Rasku Finland 10 431 1.3× 243 1.2× 185 1.0× 78 0.5× 83 0.5× 13 1.2k
D. Sakthisekaran India 22 488 1.5× 296 1.4× 135 0.7× 77 0.5× 90 0.6× 45 1.4k
KiHwan Bae South Korea 16 432 1.3× 268 1.3× 106 0.6× 78 0.5× 76 0.5× 20 871
Janelle M. Landau United States 7 545 1.6× 231 1.1× 103 0.6× 83 0.5× 125 0.8× 10 1.6k
Chang‐Xin Zhou China 23 590 1.8× 304 1.4× 166 0.9× 104 0.6× 128 0.8× 73 1.4k
Xiaofeng Ma China 24 757 2.3× 324 1.5× 92 0.5× 256 1.5× 107 0.7× 50 1.4k
Fengming Xu Japan 19 554 1.7× 319 1.5× 102 0.5× 70 0.4× 154 1.0× 28 1.1k
Yi‐Chen Chia Taiwan 19 585 1.8× 257 1.2× 170 0.9× 46 0.3× 138 0.9× 25 1.2k

Countries citing papers authored by J. YAMAHARA

Since Specialization
Citations

This map shows the geographic impact of J. YAMAHARA's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. YAMAHARA with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. YAMAHARA more than expected).

Fields of papers citing papers by J. YAMAHARA

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. YAMAHARA. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. YAMAHARA. The network helps show where J. YAMAHARA may publish in the future.

Co-authorship network of co-authors of J. YAMAHARA

This figure shows the co-authorship network connecting the top 25 collaborators of J. YAMAHARA. A scholar is included among the top collaborators of J. YAMAHARA based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. YAMAHARA. J. YAMAHARA is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Lian‐Di, Yufei Pan, Robert A. Batey, et al.. (2015). Mitigation of Insulin Resistance by Mangiferin in a Rat Model of Fructose-Induced Metabolic Syndrome Is Associated with Modulation of CD36 Redistribution in the Skeletal Muscle. Journal of Pharmacology and Experimental Therapeutics. 356(1). 74–84. 32 indexed citations
2.
Huang, Tom, Lei He, Qiaojing Qin, et al.. (2007). Salacia oblonga root decreases cardiac hypertrophy in Zucker diabetic fatty rats: inhibition of cardiac expression of angiotensin II type 1 receptor. Diabetes Obesity and Metabolism. 10(7). 574–585. 33 indexed citations
3.
Peng, Guang, et al.. (2005). Salacia oblonga root improves postprandial hyperlipidemia and hepatic steatosis in Zucker diabetic fatty rats: Activation of PPAR-α. Toxicology and Applied Pharmacology. 210(3). 225–235. 83 indexed citations
4.
Huang, Tom, Guang Peng, Bhavani Prasad Kota, et al.. (2005). Anti-diabetic action of flower extract: Activation of PPAR-γ and identification of an active component. Toxicology and Applied Pharmacology. 207(2). 160–169. 236 indexed citations
5.
Matsuda, Hisashi, et al.. (1999). Inhibition of Gastric Emptying by Triterpene Saponin, Momordin Ic, in Mice: Roles of Blood Glucose, Capsaicin-Sensitive Sensory Nerves, and Central Nervous System. Journal of Pharmacology and Experimental Therapeutics. 289(2). 729–734. 59 indexed citations
6.
7.
8.
9.
Yoshikawa, Masato, Satoshi Yoshizumi, Toshiyuki Murakami, et al.. (1996). Medicinal Foodstuffs. II. On the Bioactive Constituents of the Tuber of Sagittaria trifolia L. (Kuwai, Alismataceae): Absolute Stereostructures of Trifoliones A, B, C, and D, Sagittariosides a and b, and Arabinothalictoside.. Chemical and Pharmaceutical Bulletin. 44(3). 492–499. 17 indexed citations
10.
Kawamori, Toshihiko, Tsuyoshi Tanaka, Akira Hara, J. YAMAHARA, & Hideki Mori. (1995). Modifying effects of naturally occurring products on the development of colonic aberrant crypt foci induced by azoxymethane in F344 rats.. PubMed. 55(6). 1277–82. 81 indexed citations
11.
YAMAHARA, J., Hisashi Matsuda, Hiroshi Shimoda, et al.. (1994). Development of Bioactive Functions in Hydrangeae Dulcis Folium. II. Antiulcer, Antiallergy, and Cholagoic Effects of the Extract from Hydrangeae Dulcis Folium. YAKUGAKU ZASSHI. 114(6). 401–413. 23 indexed citations
12.
13.
Yoshikawa, Masaaki, Emiko Harada, Y. Naitoh, et al.. (1994). Development of Bioactive Functions in Hydrangeae Dulcis Folium. III. On the Antiallergic and Antimicrobial Principles of Hydrangeae Dulcis Folium. (1). Thunberginols A, B, and F.. Chemical and Pharmaceutical Bulletin. 42(11). 2225–2230. 86 indexed citations
14.
15.
Yoshikawa, Masayuki, S Yamaguchi, Toshiyuki Murakami, et al.. (1993). Absolute Stereostructures of Trifoliones A, B, C, and D, New Biologically Active Diterpenes from the Tuber of Sagittaria trifolia L.. Chemical and Pharmaceutical Bulletin. 41(9). 1677–1679. 16 indexed citations
16.
Yoshikawa, Masato, et al.. (1992). Thunberginols A, B, and F, new antiallergic and antimicrobial principles from Hydrangeae Dulcis Folium.. Chemical and Pharmaceutical Bulletin. 40(11). 3121–3123. 51 indexed citations
17.
Yoshikawa, Masayuki, Emiko Uchida, Naoto Chatani, et al.. (1992). Thunberginols C, D, and E, new antiallergic and antimicrobial dihydroisocoumarins, and thunberginol G 3'-O-glucoside and (-)-hydrangenol 4'-O-glucoside, new dihydroisocoumarin glycosides, from Hydrangeae Dulcis Folium.. Chemical and Pharmaceutical Bulletin. 40(12). 3352–3354. 52 indexed citations
18.
Sugie, Shigeyuki, et al.. (1992). Modifying Effects of Fungal and Herb Metabolites on Azoxymethane‐induced Intestinal Carcinogenesis in Rats. Japanese Journal of Cancer Research. 83(12). 1273–1278. 86 indexed citations
19.
Mori, Hirohito, Naoki Yoshimi, Shigeyuki Sugie, et al.. (1992). Inhibitory effect of 5-hydroxy-4-(2-phenyl-(E)-ethenyl)-2(5H)-furanone, a novel synthesized retinoid, on azoxymethane-induced intestinal carcinogenesis in rats. Cancer Letters. 66(2). 93–98. 17 indexed citations
20.
Matsuda, Hisashi, et al.. (1991). Imaging Analysis of Antiulcer Action and the Active Constituent of Atractylodis Rhizoma. YAKUGAKU ZASSHI. 111(1). 36–39. 24 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M. A. Ocete Breakdown of academic impact, for papers by Johji YAMAHARA Breakdown of academic impact, for papers by Sirpa Rasku Breakdown of academic impact, for papers by D. Sakthisekaran Breakdown of academic impact, for papers by KiHwan Bae Breakdown of academic impact, for papers by Janelle M. Landau Breakdown of academic impact, for papers by Chang‐Xin Zhou Breakdown of academic impact, for papers by Xiaofeng Ma Breakdown of academic impact, for papers by Fengming Xu Breakdown of academic impact, for papers by Yi‐Chen Chia
Rankless by CCL
2026